H|T: The Healthtech Times – Canadian pharmaceutical research spending dropped in 2022
Plus: Myanmar Molecular seeks Health Canada approval.
Plus: Myanmar Molecular seeks Health Canada approval.
Ontraccr’s platform digitizes operational workflows in the construction industry.
Ziing looks to expand its Canadian delivery network with second acquisition this year.
Plus: US resistance has Shein eyeing UK to IPO.
Cognito plans to expand its mental health services across Canada this year.
Celesta will help McMaster-affiliated entrepreneurs commercialize their innovations.
Inovia Capital-led round aimed at cementing firm’s presence in the United States and Canada.
Plus: Six months after launch, Toronto’s Ideogram secures $80 million.
Synctera launched its embedded banking platform for Canada in December 2023.
Plus: Certn’s new president targets growth over acquisitions.
Miovision acquired traffic data collection company CJ Hensch & Associates in January.
The deal values Plusgrade at over $2 billion, according to The Globe and Mail.
Plus: How Flinks is building middleware for open banking.
Plus: Abridge raises $150 million to increase the speed and accuracy of medical note-taking.
Stern says he will remain with the company as a strategic advisor.